IDEXX LABORATORIES INC /DE Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Idexx Laboratories Inc /De quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • Idexx Laboratories Inc /De Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $34.8M, a 12.4% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $34.8M -$4.93M -12.4% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $39.7M +$446K +1.14% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $39.3M -$982K -2.44% Dec 31, 2021 10-K 2024-02-22
Q4 2020 $40.3M +$30.8M +326% Dec 31, 2020 10-K 2024-02-22
Q4 2019 $9.45M +$3.24M +52.2% Dec 31, 2019 10-K 2023-02-16
Q4 2018 $6.21M +$1K +0.02% Dec 31, 2018 10-K 2022-02-16
Q4 2017 $6.21M +$1.32M +27% Dec 31, 2017 10-K 2021-02-12
Q4 2016 $4.89M Dec 31, 2016 10-K 2018-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.